| Subject: | FDA Issues Reminder About Avoiding Glucose Monitoring Errors in Patients Receiving Other Sugars |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Wed, 8 Feb 2006 - 10:00 am |
| The FDA has issued a reminder about the potential for falsely elevated glucose readings in patients who are also receiving products that contain other sugars. These products include:
Oral xylose -Parenterals that contain maltose or galactose -Peritoneal dialysis solutions that contain icodextrin
In a recent case of patient death due to falsely elevated glucose readings, a patient was given aggressive insulin treatment. However, the glucose... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. The StayAlert! system was designed by healthcare professionals actively working in the healthcare environment, who were faced with attempting to competently provide quality care and services while "doing more with less". StayAlert! provides the answer to efficiently performing a variety of required job components from one centralized virtual location. StayAlert! improves data sharing and communications, thus reducing cost, broadening access and providing a system of documentation and follow-up. |
|
